2nd Quarter - Report — ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS (2025)

Firm

ACADIA PHARMACEUTICALS

Client

ACADIA PHARMACEUTICALS

Income

—

Expenses

$500,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).

Lobbyist	Covered position, as disclosed
MICHAEL MATTOON	—
SARAH TODD TELLOCK New	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1414 (119th), H.R. 1 (119th)

Health Issues HCR

Implementation of the Inflation Reduction Act of 2022, Orphan Cures Act (HR 946, S 1862), Give Kids A Chance (HR 1262, S 932), Cameron's Law (HR 1414), Accelerating Kids Access to Care Act (HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930).

Lobbyist	Covered position, as disclosed
MICHAEL MATTOON	—
SARAH TODD TELLOCK New	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1509 (119th), H.R. 1414 (119th), H.R. 1262 (119th), H.R. 3731 (119th), H.R. 946 (119th)

Medicare/Medicaid MMM

Implementation of the Inflation Reduction Act of 2022, Issues related to protecting patient access to medicines in Medicare, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Orphan Cures Act (HR 946, S 1862), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Accelerating Kids Access to Care Act (HR 1509, S 752).

Lobbyist	Covered position, as disclosed
MICHAEL MATTOON	—
SARAH TODD TELLOCK New	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 946 (119th), H.R. 1509 (119th), H.R. 1492 (119th), H.R. 1 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.